Anandamide in the dorsal periaqueductal gray inhibits sensory input without a correlation to sympathoexcitation

There is growing literature supporting cannabinoids as a potential therapeutic for pain conditions. The development of chronic pain has been associated with reduced concentrations of the endogenous cannabinoid anandamide (AEA) in the midbrain dorsal periaqueductal gray (dPAG), and microinjections of...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Christopher J., Hopp, Francis A., Hogan, Quinn H., Dean, Caron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755024/
https://www.ncbi.nlm.nih.gov/pubmed/36531614
http://dx.doi.org/10.1016/j.ynpai.2022.100104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755024/
https://www.ncbi.nlm.nih.gov/pubmed/36531614
http://dx.doi.org/10.1016/j.ynpai.2022.100104

Ejemplares similares